QuadMedicine
QuadMedicine is a Improved skin immunity and improved medication convenience Biobetter Microneedle.
Funding reportedLast round: Series C
What company datasets say QuadMedicine raised
Funding, as reported
Reported in all15Bin the source's currency
Rounds3
Last roundSeries C
Last round dateMay 2022
Investors listed7
On 2 portfolio pages
Investors who name them
Each firm lists QuadMedicine on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Health Care in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put QuadMedicine in front of investors. Or tell us what we have wrong.